Marlies Ballegeer

Gent, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base.

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base.

Journal: Nature communications

Published: August 16, 2024

A neutralizing single-domain antibody that targets the trimer interface of the human metapneumovirus fusion protein.

A neutralizing single-domain antibody that targets the trimer interface of the human metapneumovirus fusion protein.

Journal: mBio

Published: December 20, 2023

Nanoparticle display of neuraminidase elicits enhanced antibody responses and protection against influenza A virus challenge.

Nanoparticle display of neuraminidase elicits enhanced antibody responses and protection against influenza A virus challenge.

Journal: NPJ vaccines

Published: November 08, 2023

Rethinking IL-1 Antagonism in Respiratory Viral Infections: A Role for IL-1 Signaling in the Development of Antiviral T Cell Immunity.

Rethinking IL-1 Antagonism in Respiratory Viral Infections: A Role for IL-1 Signaling in the Development of Antiviral T Cell Immunity.

Journal: International journal of molecular sciences

Published: September 24, 2023

Cleavage of cFLIP restrains cell death during viral infection and tissue injury and favors tissue repair.

Cleavage of cFLIP restrains cell death during viral infection and tissue injury and favors tissue repair.

Journal: Science advances

Published: July 26, 2023

ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infection.

ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infection.

Journal: Mucosal immunology

Published: November 08, 2021

Influenza Neuraminidase Characteristics and Potential as a Vaccine Target.

Influenza Neuraminidase Characteristics and Potential as a Vaccine Target.

Journal: Frontiers in immunology

Published: September 30, 2021

In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression.

In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression.

Journal: mBio

Published: July 13, 2021

A vulnerable, membrane-proximal site in human respiratory syncytial virus F revealed by a prefusion-specific single-domain antibody.

A vulnerable, membrane-proximal site in human respiratory syncytial virus F revealed by a prefusion-specific single-domain antibody.

Journal: Journal of virology

Published: March 11, 2021

An Inside Job: Applications of Intracellular Single Domain Antibodies.

An Inside Job: Applications of Intracellular Single Domain Antibodies.

Journal: Biomolecules

Published: November 20, 2020

Cell-Mediated Responses to Human Metapneumovirus Infection.

Cell-Mediated Responses to Human Metapneumovirus Infection.

Journal: Viruses

Published: March 24, 2020

The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration.

The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration.

Journal: Molecular therapy. Nucleic acids

Published: February 21, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026